These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

107 related articles for article (PubMed ID: 7515751)

  • 1. Determination of two neuropeptide growth factor antagonists, [D-Arg1,D-Phe5,D-Trp7,9,Leu11]-substance P and [Arg6,D-Trp7,9,N-MePhe8]- substance P(6-11), by high-performance liquid chromatography with electrochemical detection.
    Cummings J; MacLellan A; Langdon SP; Rozengurt E; Smyth JF
    J Chromatogr B Biomed Appl; 1994 Mar; 653(2):195-203. PubMed ID: 7515751
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Stability and in vitro metabolism of the mitogenic neuropeptide antagonists [D-Arg1,D-Phe5, D-Trp7,9, Leu11]-substance P and [Arg6, D-Trp7,9, MePhe8]-substance P (6-11) characterized by high-performance liquid chromatography.
    Cummings J; MacLellan A; Langdon SP; Smyth JF
    J Pharm Biomed Anal; 1994 Jun; 12(6):811-9. PubMed ID: 7522585
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Development of a gradient elution high-performance liquid chromatography assay with ultraviolet detection for the determination in plasma of the anticancer peptide [Arg6, D-Trp7,9, mePhe8]-substance P (6-11) (antagonist G), its major metabolites and a C-terminal pyrene-labelled conjugate.
    Cummings J; MacLellan AJ; Mark M; Jodrell DI
    J Chromatogr B Biomed Sci Appl; 1999 Sep; 732(2):277-85. PubMed ID: 10517349
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [D-Arg1,D-Phe5,D-Trp7,9,Leu11]substance P, a potent bombesin antagonist in murine Swiss 3T3 cells, inhibits the growth of human small cell lung cancer cells in vitro.
    Woll PJ; Rozengurt E
    Proc Natl Acad Sci U S A; 1988 Mar; 85(6):1859-63. PubMed ID: 2450349
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Processing of [D-Arg1,D-Phe5,D-Trp7,9,Leu11]substance P in xenograft bearing Nu/Nu mice.
    Jones DA; MacLellan AJ; Cummings J; Ritchie AA; Langdon SP; Smyth JF
    Peptides; 1997; 18(7):1073-7. PubMed ID: 9357069
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Metabolism of the broad-spectrum neuropeptide growth factor antagonist: [D-Arg1, D-Phe5, D-Trp7,9, Leu11]-substance P.
    Jones DA; Cummings J; Langdon SP; Maclellan AJ; Higgins T; Rozengurt E; Smyth JF
    Br J Cancer; 1996 Mar; 73(6):715-20. PubMed ID: 8611370
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Interaction of a substance P agonist and of substance P antagonists with lipid membranes. A thermodynamic analysis.
    Seelig A
    Biochemistry; 1992 Mar; 31(11):2897-904. PubMed ID: 1372515
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of intranigral substance P and neurokinin A on striatal dopamine release--I. Interactions with substance P antagonists.
    Reid MS; Herrera-Marschitz M; Hökfelt T; Ohlin M; Valentino KL; Ungerstedt U
    Neuroscience; 1990; 36(3):643-58. PubMed ID: 1700329
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Broad spectrum neuropeptide antagonists inhibit the growth of small cell lung cancer in vivo.
    Langdon S; Sethi T; Ritchie A; Muir M; Smyth J; Rozengurt E
    Cancer Res; 1992 Aug; 52(16):4554-7. PubMed ID: 1379515
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [D-Arg1, D-Phe5, D-Trp7,9, Leu11] substance P induces apoptosis in lung cancer cell lines in vitro.
    Reeve JG; Bleehen NM
    Biochem Biophys Res Commun; 1994 Mar; 199(3):1313-9. PubMed ID: 7511895
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Reversed-phase high-performance liquid chromatography and capillary electrophoresis in the stability study of the neuropeptide growth factor antagonist [Arg6,D-Trp7,9,MePhe8]-substance P (6-11): a comparative study.
    Reubsaet JL; Beijnen JH; Bult A; Teeuwsen J; Koster EH; Waterval JC; Underberg WJ
    Anal Biochem; 1994 Jul; 220(1):98-102. PubMed ID: 7526736
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Differential modulation of bombesin-stimulated phospholipase C beta and mitogen-activated protein kinase activity by [D-Arg1,D-Phe5,D-Trp7,9,Leu11]substance P.
    Mitchell FM; Heasley LE; Qian NX; Zamarripa J; Johnson GL
    J Biol Chem; 1995 Apr; 270(15):8623-8. PubMed ID: 7536738
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [D-Arg1, D-Phe5, D-Trp7,9, Leu11] substance P inhibits the growth of human small cell lung cancer xenografts in vivo.
    Everard MJ; Macaulay VM; Millar JL; Smith IE
    Eur J Cancer; 1993; 29A(10):1450-3. PubMed ID: 7691115
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Precolumn fluorescence derivatization of the antagonist [Arg6,D-Trp7,9,MePhe8]-substance P[6-11] with benzoin in high-performance liquid chromatography and selective detection of arginine-containing fragments in its degradation products.
    Cui H; Reubsaet JL; Bult A
    J Chromatogr A; 1996 Jun; 736(1-2):91-6. PubMed ID: 8673253
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [D-Arg1,D-Phe5,D-Trp7,9,Leu11]substance P, a neuropeptide antagonist, blocks binding, Ca2(+)-mobilizing, and mitogenic effects of endothelin and vasoactive intestinal contractor in mouse 3T3 cells.
    Fabregat I; Rozengurt E
    J Cell Physiol; 1990 Oct; 145(1):88-94. PubMed ID: 1698796
    [TBL] [Abstract][Full Text] [Related]  

  • 16. In vitro effects of substance P analogue [D-Arg1, D-Phe5, D-Trp7,9, Leu11] substance P on human tumour and normal cell growth.
    Everard MJ; Macaulay VM; Miller JL; Smith IE
    Br J Cancer; 1992 Mar; 65(3):388-92. PubMed ID: 1373071
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [D-Arg1,D-Phe5,D-Trp7,9,Leu11]Substance P acts as a biased agonist toward neuropeptide and chemokine receptors.
    Jarpe MB; Knall C; Mitchell FM; Buhl AM; Duzic E; Johnson GL
    J Biol Chem; 1998 Jan; 273(5):3097-104. PubMed ID: 9446627
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Solution conformation of Substance P antagonists-[D-Arg1, D-Trp7,9, Leu11]-SP, [D-Arg1, D-Pro2, D-Trp7,9, Leu11]-SP and [D-Pro2, D-Trp7,9]-SP by CD, NMR and MD simulations.
    Prabhu A; Malde A; Coutinho E; Srivastava S
    Peptides; 2005 May; 26(5):875-85. PubMed ID: 15808918
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Structural identification of the degradation products of the antitumor peptide antagonist [Arg6,D-Trp7,9,MePhe8]substance P (6-11).
    Reubsaet JL; Beijnen JH; Bult A; Hop E; Vermaas R; Kellekule Y; Kettenes-van den Bosch JJ; Underberg WJ
    Anal Chem; 1995 Dec; 67(23):4431-6. PubMed ID: 8633781
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of the substance P antagonist, (D-Arg1, D-Pro2, D-Trp7,9, Leu11)-SP on the miotic response to substance P, antidromic trigeminal nerve stimulation, capsaicin, prostaglandin E1, compound 48/80 and histamine.
    Mandahl A; Bill A
    Acta Physiol Scand; 1984 Jan; 120(1):27-35. PubMed ID: 6202097
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.